title: [Tuberculosis].
abstract: Tuberculosis ranges among the most important causes of morbidity and mortality worldwide. The emergence of drug-resistant strains of Mycobacterium tuberculosis, especially in the WHO Region Europe, is of serious concern. Recently, important advances have been achieved in the areas of tuberculosis prevention, diagnosis and treatment and in the management of patients with multidrug-resistant tuberculosis. Recent highlights are being presented in this mini-review.
authors.affiliation: Klinische Infektiologie, Forschungszentrum Borstel.
authors.forename: Barbara
authors.initials: B
authors.lastname: Kalsdorf
authors.affiliation: Klinische Infektiologie, Forschungszentrum Borstel.
authors.forename: Ioana D
authors.initials: ID
authors.lastname: Olaru
authors.affiliation: Klinische Infektiologie, Forschungszentrum Borstel.
authors.forename: Christoph
authors.initials: C
authors.lastname: Lange
authors.affiliation: Klinische Infektiologie, Forschungszentrum Borstel.
authors.forename: Jan
authors.initials: J
authors.lastname: Heyckendorf
mesh_terms: D000995:Antitubercular Agents / Q000008:administration & dosage*; D020022:Genetic Predisposition to Disease / Q000235:genetics; D005820:Genetic Testing / Q000379:methods*; D006801:Humans; D057285:Precision Medicine / Q000379:methods; D014376:Tuberculosis / Q000175:diagnosis* / Q000188:drug therapy* / Q000235:genetics
chemical_list: D000995:Antitubercular Agents